MSD WORLDWIDE BUSINESS DEVELOPMENT & LICENSING
|
|
- Laurence Chandler
- 7 years ago
- Views:
Transcription
1 MSD WORLDWIDE BUSINESS DEVELOPMENT & LICENSING Manfred Horst Director, Business Development & Licensing MSD Biovaria Munich, May 11, 2015 *MSD IS KNOWN AS MERCK & CO. IN THE UNITED STATES AND CANADA
2 FORWARD-LOOKING STATEMENT This presentation includes forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of These statements are based upon the current beliefs and expectations of MSD s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; MSD s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of MSD s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. MSD undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in MSD s 2014 Annual Report on Form 10-K and the company s other filings with the Securities and Exchange Commission (SEC) available at the SEC s Internet site ( 2
3 You ve discovered something significant Now discover MSD! Your MSD contact for: France, Germany, Israel, Italy, Russia and Switzerland Manfred Horst, MD, PhD, MBA Director, Business Development & Licensing, MRL MSD 34, Avenue Léonard de Vinci Courbevoie Cedex, France Phone:
4 Key Company Facts COMPANY NAME We operate as MSD globally except for in the US and Canada, where we operate as Merck. BUSINESSES Pharmaceuticals, Vaccines, Biologics and Animal Health 2014 FINANCIALS GLOBAL OPERATIONS Revenue: $42.2 billion R&D Expense: $7.2 billion MSD operates in more than 140 countries EMPLOYEES Approximately 70,
5 Positioned for Long-Term Growth through Innovation 2015 HOLDS A SUITE OF OPPORTUNITIES FOR MSD Seven Product Launches - KEYTRUDA (advanced melanoma) - BELSOMRA - ZONTIVITY - GARDASIL 9 - GRASTEK / RAGWITEK - VANIHEP (Japan) - ZERBAXA* Filings in HCV, Lung Cancer and Osteoporosis Regulatory Action for Multiple Programs Targeting Business Development & Licensing to Drive Long-Term Value *currently marketed by Cubist 5
6 Partnerships are Key to our Success Approximately 58% of MSD s 2014 human health revenue is attributable to alliance products and patents JANUVIA / JANUMET* REMICADE ZETIA / VYTORIN GARDASIL COZAAR/HYZAAR ZOSTAVAX Licensed Products or Patents: 58% of revenue *Method of use patent Revenue includes 50% of full year JV revenue (Sanofi-Pasteur MSD) 6
7 MSD Scouts brought forth opportunities And Served as Gatekeepers as well MSD Business Development & Licensing Key Acquisitions & Alliances Signed 697 Confidentiality-In agreements 1290 Opportunities reviewed 8672 Opportunities Received But No does not mean Never
8 A New Organization with Increased Global Reach MSD s new BD&L organization resides fully within Merck Research Laboratories (MRL) Growing strategically-located BD&L bases in Boston, San Francisco, London and Asia The MRL Venture Fund (MRLV) is a key component of our commitment to external innovation Iain Dukes, Senior Vice President, BD&L Karen Akinsanya Early-Stage Assessment US & EU (London) Ji Li Late-Stage Assessment Ben Thorner BD&L Boston & San Francisco Joanne Smith-Farrell Transactions Meeta Chatterjee Business Strategy & Operations BD&L, Far East Josh Resnick, MRL Ventures 8
9 2013 Present: MSD BD&L Has a New Approach to Accessing External Innovation OPPORTUNISTIC APPROACH We are interested in any and all opportunities that have a strong scientific rationale No limits surrounding therapeutic area, stage of development or modality FOCUS ON EMERGING SCIENCE A sharper focus on emerging areas of science with an aim to build programs around the most promising approaches UNAMBIGUOUS, PROMOTABLE ADVANTAGES We are seeking programs that will deliver products with unambiguous, promotable advantages over available therapies rather than differentiation through an improved safety profile alone 9
10 Changing our Focus Then Franchise driven Defined areas of interest An emphasis on programs with POC already established Dispersed scout organization Acquisition of cutting edge platform technologies without specific product opportunities Now Idea driven Partnering early and late in areas of emerging science Applying our capabilities to breakthrough opportunities with potential for unambiguous promotable advantages. Regional BD&L hubs Enabling our pipeline and programs via cutting edge technology partnerships 10
11 Seeking Innovation at the Source: MSD Business Development & Licensing Hubs We are building Business Development & Licensing hubs in key geographies that are epicenters of scientific advancement: Boston San Francisco London Far East The strategy focuses on: Being local to build relationships with leading scientists Finding and transacting on great opportunities to supplement the MSD pipeline Raising the profile of MSD in the scientific and business communities Building quality relationships for hands-on collaboration between our scientists and external academic and biotech groups 11
12 European Business Development & Licensing Hub Based in London Karen Akinsanya Head, Early-Stage Assessment and Search & Evaluation for the European Hub Jeanette Evans Head, International Transactions Seeking partnerships with academic and biotech innovators working on therapeutic breakthroughs and enabling technologies to benefit patients around the world. Manfred Horst France, Germany, Israel, Italy, Russian and Switzerland Erik Lund Austria, Baltic States, Benelux, Central EU, Greece, The Balkans, Turkey and Scandinavia Rob Pinnock Ireland, Portugal, South Africa, Spain and United Kingdom Karen McGurk Transactions 12
13 DISCOVERING A BIG IDEA. A novel approach, robust scientific data and a vision for your innovation to bring new hope to patients with serious diseases. DELIVERING BREAKTHROUGH MEDICINES. Integrated global resources for discovery research, clinical development, regulatory, commercial strategy and a sales organization. 13
Third-Quarter 2015 Earnings Conference Call Executive Commentary Highlights. October 27, 2015
Third-Quarter 2015 Earnings Conference Call Executive Commentary Highlights October 27, 2015 Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA This presentation of Merck & Co., Inc.,
More informationRichard T. Clark Chief Executive Officer and President. Executing on Our Strategy
Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS
More informationMedia Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com
News Release FOR IMMEDIATE RELEASE Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) 837-2550 (908) 740-1879 annick.robinson@merck.com Merck's HPV Vaccine, GARDASIL 9, now available
More information18.5 Percent Overall Response Rate Observed in Pembrolizumab-Treated Patients with this Aggressive Form of Breast Cancer
News Release Media Contacts: Annick Robinson Investor Contacts: Joseph Romanelli (514) 837-2550 (908) 740-1986 Stephanie Lyttle NATIONAL Public Relations (514) 843-2365 Justin Holko (908) 740-1879 Merck
More informationIncreasing Innovation in R&D - Seizing early stage external growth opportunities
Increasing Innovation in R&D - Seizing early stage external growth opportunities Paul R. Eynott, PhD sanofi-aventis, US paul.eynott@sanofi-aventis.com -1- Sommaire -2- CHRISTOPHER A. VIEHBACHER Chief Executive
More informationNews Release. FOR IMMEDIATE RELEASE Media Contact: Annick Robinson (438) 837-2550 (908) 740-1898
News Release FOR IMMEDIATE RELEASE Media Contact: Annick Robinson (438) 837-2550 Investor Contact: Amy Klug (908) 740-1898 Merck Receives Approval of ZEPATIER (elbasvir/grazoprevir) in Canada for the Treatment
More informationFOR IMMEDIATE RELEASE Media Contacts: Lainie Keller Investor Contacts: Teri Loxam (908) 236-5036 (908) 740-1986 (908) 740-1801 (908) 740-1879
News Release FOR IMMEDIATE RELEASE Media Contacts: Lainie Keller Investor Contacts: Teri Loxam (908) 236-5036 (908) 740-1986 Steven Cragle Justin Holko (908) 740-1801 (908) 740-1879 Merck Announces Fourth-Quarter
More informationThe Future of Consumer Health Care
The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More
More informationZ E N T I VA AT G L A N C E. We a i m t o b e y o u r va l u e d ge n e r i c s partner
Z E N T I VA AT G L A N C E We a i m t o b e y o u r va l u e d ge n e r i c s partner Poland Czech Republic Germany United Kingdom France Portugal Switzerland Italy Slovenia Estonia Latvia Lithuania Slovakia
More informationFORM 6-K. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549. Report of Foreign Private Issuer
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2011
More informationUniversità Vita-Salute San Raffaele. Prof. Lorenzo Dagna Delegate for International Relations Milan, October 3 rd 2011
Università Vita-Salute San Raffaele Prof. Lorenzo Dagna Delegate for International Relations Milan, October 3 rd 2011 Faculty of Medicine Faculty of Philosophy Faculty of Psychology Università Vita-Salute
More informationNormand Laberge Vice-President Regulatory & Scientific Affairs Rx&D. Globalization of Clinical Research: Trends & Implications for Canada
Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D Globalization of Clinical Research: Trends & Implications for Success Rates by Phase and Therapeutic Area Source: Nature Reviews Drug
More informationGlobal Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
More informationFit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing
Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,
More informationProfile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Boston Along with San Francisco,
More informationAdditional 50 patients enrolled in KEYNOTE-001 with analyses planned using Merck s proprietary PD-L1 assay at one percent and 50 percent cut points
News Release Media Contacts: Annick Robinson Dominique Quirion Merck NATIONAL Annick.robinson@merck.com dquirion@national.ca 514 428-2890 514 843-2302 Investor Contacts: Justin Holko: (+1 908-423-5088
More informationHealthcare Coalition on Data Protection
Healthcare Coalition on Data Protection Recommendations and joint statement supporting citizens interests in the benefits of data driven healthcare in a secure environment Representing leading actors in
More information34 th Annual J. P. Morgan Healthcare Conference. January 11 th -13 th, 2016 San Francisco
34 th Annual J. P. Morgan Healthcare Conference January 11 th -13 th, 2016 San Francisco 1 Business update Q3 and nine months 2015 2 Strong underlying operational performance Q3/9m Highlights Q3 Performance
More informationOPKO Health to Acquire Bio-Reference Laboratories
OPKO Health to Acquire Bio-Reference Laboratories - Complementary in-depth expertise in diagnostics business with state of the art experience in use of genomic data for personalized therapy - Acquisition
More informationThe World's Top 100 Pharmaceutical Companies
Brochure More information from http://www.researchandmarkets.com/reports/1878687/ The World's Top 100 Pharmaceutical Companies Description: Did you know? - Dr. Jeremy Levin is Senior Vice President, Strategy,
More informationPartnering with the continuous flow of external innovations is central to the success of our research and development efforts.
C O M B I N I N G O U R S T R E N G T H S 2 E M B R A C I N G P A R T N E R S H I P S C O M B I N I N G O U R S T R E N G T H S We are strongly committed to partnership success. We recognize that the greatest
More informationQuestionnaire on International sourcing
General information Questionnaire on International sourcing 1. Are you part of an enterprise group? (Tick the relevant boxes) a. Yes, the group head (ultimate controlling institutional unit) of an all-resident
More informationMultiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013
Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012
More informationThe presentation and paper p that will follow is within the VISION practice on the universities of the future available at
New perspectives for Master Study Programs in Europe The opportunities of internationalization and the case of the MBA 25, October 2011 BOLOGNA SEMINAR BERLIN 1 The presentation and paper p that will follow
More informationMost countries will experience an increase in pharmaceutical spending per capita by 2018
6 Most countries will experience an increase in pharmaceutical spending per capita by 218 Pharmaceutical spending per capita, 213 versus 218 1,6 1,4 Pharmaceutical Spend per Capita 1,2 1, 8 6 4 2 US Japan
More informationTax Initiatives The Common Reporting Standard
Treasury and Trade Solutions February 2016 Tax Initiatives The Common Reporting Standard The Common Reporting Standard (CRS) The Common Reporting Standard - Overview The Common Reporting Standard ( CRS
More informationMSD Information Technology Global Innovation Center. Digitization and Health Information Transparency
MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology
More informationGLOBAL EDUCATION PROGRAM
GLOBAL EDUCATION PROGRAM RUSSIAN FEDERATION GOVERNMENT-SPONSORED PROGRAM THAT OFFERS RUSSIAN CITIZENS AN OPPORTUNITY TO STUDY AT LEADING FOREIGN UNIVERSITIES REGULATIONS: ABOUT GEP http://educationglobal.ru/o_programme/
More informationNaci Balkan Department of Computer Science and Electronic Engineering University of Essex, UK
Novel Gain Materials and Devices Based on III N V compounds COST Action: MP0805 http://www.essex.ac.uk/dces/cost_mp805/index.html Naci Balkan Department of Computer Science and Electronic Engineering University
More informationSarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com
Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 shaecker@celltherapygroup.com PROFILE Successful Senior Executive, skilled in Corporate Development including Business
More informationThe big pay turnaround: Eurozone recovering, emerging markets falter in 2015
The big pay turnaround: Eurozone recovering, emerging markets falter in 2015 Global salary rises up compared to last year But workers in key emerging markets will experience real wage cuts Increase in
More informationForeign Taxes Paid and Foreign Source Income INTECH Global Income Managed Volatility Fund
Income INTECH Global Income Managed Volatility Fund Australia 0.0066 0.0375 Austria 0.0045 0.0014 Belgium 0.0461 0.0138 Bermuda 0.0000 0.0059 Canada 0.0919 0.0275 Cayman Islands 0.0000 0.0044 China 0.0000
More informationReport on Government Information Requests
Report on Government Information January 1 - June 30, 2015 Apple takes our commitment to protecting your data very seriously and we work incredibly hard to deliver the most secure hardware, software and
More informationHow does a venture capitalist appraise investment opportunities?
1 How does a venture capitalist appraise investment opportunities? Michael Queen - Finance Director, 3i Group plc A presentation to: 23 Pensions Convention 2 June 23 A How presentation does a venture to:
More informationJoin our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
More informationInvestor Presentation Q4 2015
Investor Presentation Q4 2015 Forward Looking Statement These slides and any accompanying oral presentation by Intuitive Surgical, Inc. contain estimates and forward-looking statements. Actual results
More informationHong Kong Poised to be the Asia s Biotechnology Hub
Think Asia, think Hong Kong - London 13-09-2011 www.hkbio.org.hk BioTech at Science Park Your Safe and Fast Track to China Hong Kong Poised to be the Asia s Biotechnology Hub Albert Cheung Hoi Yu, Ph.D.
More informationVaccines: Poised To Deliver Significant Growth in Emerging Markets Citi Vaccine Seminar Pierre Morgon
March 23, 2011 Vaccines: Poised To Deliver Significant Growth in Emerging Markets Citi Vaccine Seminar Pierre Morgon Vice President, Franchise & Global Marketing Operations Sanofi Pasteur London Forward
More informationTELEKOM AUSTRIA SUCCESSFULLY COMPLETES SERVICE FULFILLMENT PROJECT
AMDOCS CUSTOMER success story TELEKOM AUSTRIA SUCCESSFULLY COMPLETES SERVICE FULFILLMENT PROJECT Breaking the overall transformation program into well-defined projects means that we can enjoy immediate
More informationThe Commercialization of Technology Concepts into Medical Products
The Commercialization of Technology Concepts into Medical Products Kevin J. Scanlon, Ph.D. New Zealand 2006 International BioScience Overview Pharmaceutical Industry Biotechnology Startups Investment Community
More informationPharming Group NV (Euronext: PHARM)
Pharming Group NV (Euronext: PHARM) Sijmen de Vries, MD, MBA Chief Executive Officer Annual General Meeting of Shareholders Leiden, 30 April 2015 1 Safe harbour statement The information contained in this
More informationBostik International Presence
TOTAL Group Fourth largest international oil and gas company and a world-class chemicals manufacturer Chemical industry Petro chemicals Speciality chemicals Holding company located in France, Paris La
More informationInternational Financial Reporting Standards
International Financial Reporting Standards Of Growing Importance for U.S. Companies Assurance Services there is no longer a choice Three factors may influence your need to consider IFRS. First, many organizations
More informationREFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN (POSTMENOPAUSAL VAGINAL ATROPHY) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN Executive Summary Premarin (conjugated estrogen cream): Key Metrics in the Seven Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan
More informationFact sheet: The Kyoto Protocol
Fact sheet: The Kyoto Protocol The Kyoto Protocol was adopted at the third Conference of the Parties to the UNFCCC (COP 3) in Kyoto, Japan, on 11 December 1997. The Protocol shares the objective and institutions
More informationGLOBAL DATA CENTER INVESTMENT 2013
2013 CENSUS REPORT: Global Data Center Investment 2013 GLOBAL DATA CENTER INVESTMENT 2013 2013 - Healthy Growth in Data Center Investment Globally Globally, the data center industry has continued to maintain
More informationBiosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies
Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Fern Barkalow, Ph.D, Senior Analyst, Oncology Citeline One of the biggest challenges facing biosimilar drug developers is
More informationSupported Payment Methods
Supported Payment Methods Global In the global payments market, credit cards are the most popular payment method. However, BlueSnap expands the payment selection by including not only the major credit
More informationSecond Quarter and First Half 2015 Trading Update
Second Quarter and First Half 2015 Trading Update Trading Performance Year-on-Year Gross Profit Reported ( m) Constant 2015 2014 % % Q2 145.3 137.1 +6.0% +10.6% H1 281.0 263.7 +6.6% +10.8% Q2 Gross Profit
More informationInternationalization and higher education policy: Recent developments in Finland
Internationalization and higher education policy: Recent developments in Finland Seminar on Cooperation between Russian and Finnish Institutions of Higher Education St Petersburg 5.-7.2.2008. Rector Anneli
More informationHR Outsourcing Market Forecast: 2012-2016 ~~~
HR Outsourcing Market Forecast: 2012-2016 ~~~ Market Assessment August 2012 About is a specialist BPO analyst company. provides buy-side and sell-side organizations with deeper research and analyses in
More informationSupported Payment Methods
Sell Globally in a Snap Supported Payment Methods Global In the global payments market, credit cards are the most popular payment method. However, BlueSnap expands the payment selection by including not
More informationConstructing a High-Performance Tertiary Education System in Finland
Constructing a High-Performance Tertiary Education System in Finland Jamil Salmi, 10 December 2014 The future of tertiary education? A world of science fiction? social and economic progress is achieved
More informationConsumer Credit Worldwide at year end 2012
Consumer Credit Worldwide at year end 2012 Introduction For the fifth consecutive year, Crédit Agricole Consumer Finance has published the Consumer Credit Overview, its yearly report on the international
More informationMALAYSIA: THE EMERGING EDUCATION HUB
MALAYSIA: THE EMERGING EDUCATION HUB Malaysia aspires to be a regional education hub by 2020 Since 2002, the Ministry of Higher Education has vigorously embarked on initiatives to elevate standards of
More informationOpen Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum
Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities
More informationAcquisition of Maple Financial Group s Mortgage Business
Acquisition of Maple Financial Group s Mortgage Business February 14, 2006 This document includes forward-looking statements which are made pursuant to the safe harbour provisions of the United States
More informationIFS ApplIcAtIonS For Document management
IFS Applications for Document management OUR SOLUTION S DNA When we first set out to create IFS Applications over 25 years ago, our goal was to make the most usable business software on the market. And
More information1.5 GHz Active Probe TAP1500 Datasheet
1.5 GHz Active Probe TAP1500 Datasheet Easy to use Connects directly to oscilloscopes with the TekVPI probe interface Provides automatic units scaling and readout on the oscilloscope display Easy access
More informationWither the Global Talent Pool?
Wither the Global Talent Pool? The U.S. Remains Competitive But Lacks a Strategic Approach European Component of Internationalization Strategies in North American Universities Balance - Coimbra Group Seminar-
More information2009 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative
Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative of clients 321 N. Clark Street, Suite 2800, Chicago, IL 60654 312.832.4500 Life
More informationGfK PURCHASING POWER INTERNATIONAL
GfK PURCHASING POWER INTERNATIONAL 1 Agenda 1. Europe 3 2. Americas 45 3. Asia & Near East 54 4. Afrika 66 5. Australia 68 6. Overview of countries and available levels 70 2 2 EUROPE 4 GfK
More informationNovel Targeted Immunotherapy Approach for Metastatic Melanoma Under Phase 3 Investigation
Novel Targeted Immunotherapy Approach for Metastatic Melanoma Under Phase 3 Investigation Hans S. Keirstead President, NeoStem Oncology NeoStem Presented by GTC, a conference production company 626-256-6405
More informationCompetition in the financial sector and its impact on financial intermediation. Dr Mamiko Yokoi-Arai
International Conference on Asian Market Integration and Financial Innovation February 10, 2012 Competition in the financial sector and its impact on financial intermediation Dr Mamiko Yokoi-Arai Evolution
More informationZENTIVA A SANOFI COMPANY. Corporate Presentation
ZENTIVA A SANOFI COMPANY Corporate Presentation SANOFI A global healthcare leader, focused on patients needs SANOFI A global integrated healthcare leader, focused on patients needs CORPORATE PRESENTATION
More informationChicago s Business Climate
Chicago s Business Climate Home to an unrivaled economy, workforce, and quality of life, Chicago is a thriving metropolis, yet a tight-knit community for business and residents. The city s dynamic character
More informationThe Role of Banks in Global Mergers and Acquisitions by James R. Barth, Triphon Phumiwasana, and Keven Yost *
The Role of Banks in Global Mergers and Acquisitions by James R. Barth, Triphon Phumiwasana, and Keven Yost * There has been substantial consolidation among firms in many industries in countries around
More informationExecutive MBA Incoming Students 2013
Executive MBA Incoming Students 2013 Talent and Diversity Snapshot Nationalities Students of 59 different nationalities Cameroon China Mexico Norway Switzerland France Georgia Mali Finland Australia U.S.
More informationCONSIDERATIONS WHEN CONSTRUCTING A FOREIGN PORTFOLIO: AN ANALYSIS OF ADRs VS ORDINARIES
THE APERIO DIFFERENCE. Authors Michael Branch, CFA Ran Leshem CONSIDERATIONS WHEN CONSTRUCTING A FOREIGN PORTFOLIO: AN ANALYSIS OF ADRs VS ORDINARIES U.S. investors can capture international equity exposure
More informationReview of R&D Tax Credit. Invitation for Submissions
Review of R&D Credit invitation for submissions Review of R&D Credit Invitation for Submissions February 2013 Economic and Fiscal Divisions Department of Finance Government Buildings, Upper Merrion Street,
More informationHigh-voltage Differential Probes TMDP0200 - THDP0200 - THDP0100 - P5200A - P5202A - P5205A - P5210A
High-voltage Differential Probes TMDP0200 - THDP0200 - THDP0100 - P5200A - P5202A - P5205A - P5210A BNC interface (P5200A probes) TekVPI interface (TMDP and THDP Series probes) TekProbe interface (P5202A,
More informationij INTERNATIONAL JURISTS Ltd Registered in England Company no.5731361 REGISTERED OFFICE c/o The Cube Barrack Road Newcastle Upon Tyne Tyne and Wear
Welcome to, a network of independent law firms., through its members, provides clients worldwide with expert legal assistance and local market knowledge. Its focus is to assist enterprises with their cross-border
More informationIpsen Jefferies Healthcare Conference
Ipsen Jefferies Healthcare Conference November 2015 IPSEN pour nom de la société - 07/04/2011 / page 1 Disclaimer This presentation includes only summary information and does not purport to be comprehensive.
More informationFood Market Diversification Approach Lithuanian case
Food Market Diversification Approach Lithuanian case Jolanta Drozdz, Artiom Volkov Agricultural Policy and Foreign Trade Division, Lithuanian Institute of Agrarian Economics CAP and the Competitiveness
More informationServier Exercises Exclusive Worldwide Licensing Option with Cellectis for UCART19, an Allogeneic CAR-T Cell Therapy for Hematological Malignancies
PRESS RELEASE Servier Exercises Exclusive Worldwide Licensing Option with Cellectis for UCART19, an Allogeneic CAR-T Cell Therapy for Hematological Malignancies Servier Also Enters Into Exclusive Global
More informationGLOBAL EDUCATION PROGRAM
GLOBAL EDUCATION PROGRAM RUSSIAN GOVERNMENT-SPONSORED SCHOLARSHIP PROGRAM THAT OFFERS RUSSIAN CITIZENS AN OPPORTUNITY TO STUDY AT LEADING FOREIGN UNIVERSITIES КSENIA IVANENKO REGULATIONS: ABOUT GEP http://educationglobal.ru/o_programme/
More informationDelivering sustainable global growth
Delivering sustainable global growth Driving profits by growing third party assets Keith Skeoch CEO, Standard Life Investments This presentation may contain certain forward-looking statements with respect
More informationLANDWELL. Solicitors. Life Sciences Unit
LANDWELL Solicitors Life Sciences Unit LANDWELL Solicitors Life Sciences Unit Our Practice Landwell Solicitors is a leading firm of business lawyers providing legal solutions to businesses in the Life
More informationAutomating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se
Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in
More informationSurface area of vineyards worldwide
O.I.V.1 IL MERCATO MONDIALE DEL VINO: SFIDE E OPPORTUNITA Fondazione Mach San Michele all Adige 9 gennaio 15 federico@castellucciconsulting.eu Area under vines Vitiviniculturalproduction potential: the
More informationOracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
More informationBusiness Development & Licensing Journal For the Pharmaceutical Licensing Groups
www.plg-uk.com Business Development & Licensing Journal For the Pharmaceutical Licensing Groups Consolidation in the generics sector Integrating business development Cross-cultural negotiations Self-reporting
More informationReport on Government Information Requests
Report on Government Information July 1 - December 31, 2015 Apple takes our commitment to protecting your data very seriously and we work incredibly hard to deliver the most secure hardware, software and
More informationDeutsche Bank 17th Annual European Leveraged Finance Conference. June 14, 2013 London
Deutsche Bank 17th Annual European Leveraged Finance Conference June 14, 2013 London Safe Harbor Statement: This presentation includes certain forward-looking statements within the meaning of Section 27A
More informationDocument Management Market Forecast: 2009-2013 ~~~
Document Management Market Forecast: 2009-2013 ~~~ Market Assessment November 2009 DOCUMENT MANAGEMENT MARKET FORECAST: 2009-2013 About is a specialist BPO analyst company. provides buy-side and sell-side
More informationBNC105 PHASE II RENAL CANCER TRIAL RESULTS
ABN 53 075 582 740 ASX ANNOUNCEMENT 19 March 2014 BNC105 PHASE II RENAL CANCER TRIAL RESULTS Results show BNC105 utility in patients with advanced disease Identified biomarkers which correlate with patient
More informationALTRAN, GLOBAL LEADER IN INNOVATION
ALTRAN, GLOBAL LEADER IN INNOVATION 2015 Q3 REVENUES 29 October 2015 DISCLAIMER This presentation contains forward-looking statements (as defined in the United States Private Securities Litigation Reform
More informationPresentation of Schneider Electric Ventures. May 2009
Schneider Electric Ventures Developer of Innovative Companies Let s s build on technologies Presentation of Schneider Electric Ventures May 2009 Schneider Electric Ventures - Developer of Innovative Companies
More informationUpdated development of global greenhouse gas emissions 2013
Updated development of global greenhouse gas emissions 2013 Hans-Joachim Ziesing Low Carbon Markets and the Legacy of Nuclear Power 19 th REFORM Group Meeting, Schloss Leopoldskron, Salzburg September
More informationBayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups
Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to
More informationCOOPERATION IN EUROPE
UNIVERSITET 1. MARTS 2013 COOPERATION IN EUROPE - IN GERMAN AND NORDIC HIGHER EDUCATION HAMBURG, JUNE 18, 2013 RECTOR LAURITZ B. HOLM-NIELSEN præsen TATION AGENDA 1. Goal: Innovation Union a competitive
More informationSUPPLEMENTARY PROTECTION CERTIFICATES FOR MEDICINAL PRODUCTS
SUPPLEMENTARY PROTECTION CERTIFICATES FOR MEDICINAL PRODUCTS A Supplementary Protection Certificate (SPC) is an Intellectual Property right which can give up to five extra years of exclusivity after a
More informationPrinciples for application of international reference pricing systems
Principles for application of international reference pricing systems International reference pricing (IRP) is a widely used element of price regulation in the vast majority of EU and EFTA countries. While
More informationSanofi Reports Positive Phase 3 Results for Toujeo (insulin glargine [rdna origin] injection, 300 U/mL)
PRESS RELEASE Sanofi Reports Positive Phase 3 Results for Toujeo (insulin glargine [rdna origin] injection, 300 U/mL) Meta-analysis of three late-stage trials in people with type 2 diabetes shows decreases
More informationEUROPEAN. Geographic Trend Report for GMAT Examinees
2011 EUROPEAN Geographic Trend Report for GMAT Examinees EUROPEAN Geographic Trend Report for GMAT Examinees The European Geographic Trend Report for GMAT Examinees identifies mobility trends among GMAT
More informationYamanouchi and Fujisawa Enter into A Basic Agreement to Merge on April 1, 2005
February 24, 2004 Yamanouchi and Fujisawa Enter into A Basic Agreement to Merge on April 1, 2005 Yamanouchi Pharmaceutical Co., Ltd. (Headquartered in Tokyo, Japan; President and CEO: Toichi Takenaka,
More informationSoftware Tax Characterization Helpdesk Quarterly June 2008
& McKenzie Software Tax Characterization Helpdesk Quarterly June 2008 Characterizing foreign software revenues is a complex challenge for large and small software firms alike. Variations in the rules around
More informationImportant Information for Investors and Securityholders. Forward-Looking Statements
Important Information for Investors and Securityholders Forward-Looking Statements Filed by Technip S.A. pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Companies: Technip S.A.,
More informationThe Texas Biotechnology Industry
The Texas Biotechnology Industry 2014 Fortune 1000 company NBTY opens state-of-the-art vitamin manufacturing plant in San Antonio See Page 15 Allergan installs new production line at Waco pharmaceutical
More informationON TRACK TO MEET FULL YEAR EXPECTATIONS. Overview. Strategic Highlights. Alison Cooper, Chief Executive, commented
ON TRACK TO MEET FULL YEAR EXPECTATIONS Overview First quarter performance in line with guidance and on track to meet full year outlook US business performing well and to plan Tobacco net revenue up 16.6%
More information